- Report
- February 2026
- 434 Pages
Global
From €5103EUR$5,850USD£4,444GBP
- Report
- February 2026
- 326 Pages
Global
From €5103EUR$5,850USD£4,444GBP
- Report
- February 2026
- 276 Pages
Global
From €5103EUR$5,850USD£4,444GBP
- Report
- February 2026
- 279 Pages
Global
From €5103EUR$5,850USD£4,444GBP
- Report
- February 2026
- 288 Pages
Global
From €5103EUR$5,850USD£4,444GBP
- Report
- February 2026
- 382 Pages
Global
From €5103EUR$5,850USD£4,444GBP
- Report
- February 2026
- 178 Pages
Global
From €5103EUR$5,850USD£4,444GBP
- Report
- February 2026
- 372 Pages
Global
From €5103EUR$5,850USD£4,444GBP
- Report
- February 2026
- 375 Pages
Global
From €5103EUR$5,850USD£4,444GBP
- Report
- February 2026
- 323 Pages
Global
From €5103EUR$5,850USD£4,444GBP
- Report
- February 2026
- 227 Pages
Global
From €5103EUR$5,850USD£4,444GBP
- Report
- February 2026
- 320 Pages
Global
From €5103EUR$5,850USD£4,444GBP
- Report
- February 2026
- 221 Pages
Global
From €5103EUR$5,850USD£4,444GBP
- Report
- February 2026
- 224 Pages
Global
From €5103EUR$5,850USD£4,444GBP
- Report
- February 2026
- 150 Pages
Global
From €5103EUR$5,850USD£4,444GBP
- Report
- February 2026
- 193 Pages
Global
From €5103EUR$5,850USD£4,444GBP
- Report
- February 2026
- 194 Pages
Global
From €5103EUR$5,850USD£4,444GBP
- Report
- February 2026
- 182 Pages
Global
From €5103EUR$5,850USD£4,444GBP
- Report
- February 2026
- 183 Pages
Global
From €5103EUR$5,850USD£4,444GBP
- Report
- February 2026
- 179 Pages
Global
From €5103EUR$5,850USD£4,444GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more